Status:

UNKNOWN

PaDAWAn: Parkinson's Disease - Adaptive Walking Assistance

Lead Sponsor:

Université Catholique de Louvain

Conditions:

Parkinson Disease

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The goal of this study is to develop and validate a haptic assistive method in order to support walking in patients with Parkinson's disease, delivered to the patient's hips through a wearable robotic...

Detailed Description

None of the existing robotic devices used for gait rehabilitation in Parkinson's disease is wearable. Thanks to the wearable robotic pelvis orthosis we will use, the rehabilitation sessions can take p...

Eligibility Criteria

Inclusion

  • Parkinson's disease diagnosis positive according to UK Brain Bank criteria
  • Hoehn and Yahr score of 1 to 3
  • Mini-mental state (MMSE) higher than 24
  • Optimal drug treatment for at least 4 weeks at the time of inclusion
  • No contraindication to physical exercising (ACSM criteria)

Exclusion

  • Not being able to understand French well enough
  • Not being in the targeted age range

Key Trial Info

Start Date :

January 27 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2023

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT04314973

Start Date

January 27 2022

End Date

June 1 2023

Last Update

June 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cliniques universitaires Saint-Luc

Brussels, Belgium, 1200

PaDAWAn: Parkinson's Disease - Adaptive Walking Assistance | DecenTrialz